Shares of EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 27.74 ($0.35) and traded as low as GBX 27.10 ($0.34). EKF Diagnostics shares last traded at GBX 28.40 ($0.35), with a volume of 169,312 shares.
EKF Diagnostics Stock Up 4.0 %
The company has a current ratio of 4.59, a quick ratio of 1.77 and a debt-to-equity ratio of 1.78. The firm has a market capitalization of £128.86 million, a P/E ratio of 2,840.00 and a beta of 0.57. The company has a 50 day simple moving average of GBX 26.12 and a two-hundred day simple moving average of GBX 27.74.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Recommended Stories
- Five stocks we like better than EKF Diagnostics
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- When to Sell a Stock for Profit or Loss
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- What is the MACD Indicator and How to Use it in Your Trading
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
